Interestingly, a prominent activation of oxidative stress pathways has been found in BTZ-sensitive MCL cells, whereas BTZ-resistant MCL cells exhibit only a minimal increase in ROS with high basal antioxidant capacity, indicating selective anti-tumor activity of BTZ in MCL cells [12]. This evidence concerns the gene CASC3 and mantle cell lymphoma.